Anaesthesia product has potential in developing world:
This article was originally published in Clinica
An anaesthesia system developed by a UK researcher that is claimed could revolutionise surgery in the developing world has been granted a UK NESTA funding award. Dr Paul Fenton, who has devised a low-cost system combining existing and new technology, has been awarded £33,000 ($47,000) to develop the device for use in remote locations where power supplies may be erratic. The device comprises an oxygen concentrator (not the conventional pipeline or cylinder gas supply), a "Fentolater" valve and modified mechanical ventolater. The NESTA (UK National Endowment for Science Technology and the Arts) award enables Dr Fenton to develop a prototype of the device over the next year.
You may also be interested in...
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.